Cardiff Oncology Inc (NASDAQ:CRDF) Has Recovered 171.68% To Date, But An Additional -36.6% Is Possible.
In last trading session, Cardiff Oncology Inc (NASDAQ:CRDF) saw 1.37 million shares changing hands with its beta currently measuring 1.73. Company’s recent per share price